Birth Control

The Second Circuit upheld a ruling in favor of pharmaceutical company Bayer in a class action products liability dispute over the Mirena intrauterine device. The plaintiffs, who claimed the IUD caused them to develop idiopathic intracranial hypertension, failed to present reliable expert opinions.

MANHATTAN — The Second Circuit upheld a ruling in favor of pharmaceutical company Bayer in a class action product liability dispute over the Mirena intrauterine device. The plaintiffs, who claimed the IUD caused them to develop idiopathic intracranial hypertension, failed to present reliable expert opinions.

Categories / Appeals, Business, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.